{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:05:32Z","timestamp":1773248732399,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to explore the genetic effects of hormones modulated through the pituitary-thyroid\/adrenal\/gonadal axis on the risk of developing venous thromboembolism (VTE) and to investigate the potentially causal relationships between them.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A two-sample Mendelian randomization (MR) design was used. The single-nucleotide polymorphisms (SNPs) used as instrumental variables for various hormones and hormone-mediated diseases were derived from published genome-wide association studies (GWASs). Summary statistics for the risk of developing VTE (including deep venous thrombosis [DVT] and pulmonary embolism [PE]) were obtained from the UK Biobank and the FinnGen consortium. Inverse-variance weighting (IVW) was applied as the primary method to analyse causal associations. Other MR methods were used for supplementary estimates and sensitivity analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A genetic predisposition to greater free thyroxine (FT4) concentrations was associated with a greater risk of developing DVT (OR\u2009=\u20091.0007, 95%CI [1.0001\u20131.0013], <jats:italic>p<\/jats:italic>\u2009=\u20090.0174) and VTE (OR\u2009=\u20091.0008, 95%CI [1.0002\u20131.0013], <jats:italic>p<\/jats:italic>\u2009=\u20090.0123). Genetically predicted hyperthyroidism was significantly associated with an increased risk of developing DVT (OR\u2009=\u20091.0685, 95%CI [1.0139\u20131.1261], <jats:italic>p<\/jats:italic>\u2009=\u20090.0134) and VTE (OR\u2009=\u20091.0740, 95%CI [1.0165\u20131.1348], <jats:italic>p<\/jats:italic>\u2009=\u20090.0110). According to the initial MR analysis, testosterone concentrations were positively associated with the risk of developing VTE (OR\u2009=\u20091.0038, 95%CI [1.004\u20131.0072], <jats:italic>p<\/jats:italic>\u2009=\u20090.0285). After sex stratification, estradiol concentrations were positively associated with the risk of developing DVT (OR\u2009=\u20091.0143, 95%CI [1.0020\u20131.0267], <jats:italic>p<\/jats:italic>\u2009=\u20090.0226) and VTE (OR\u2009=\u20091.0156, 95%CI [1.0029\u20131.0285], <jats:italic>p<\/jats:italic>\u2009=\u20090.0158) in females, while the significant relationship between testosterone and VTE did not persist. SHBG rs858518 was identified as the only SNP that was associated with an increased risk of developing VTE, mediated by estradiol, in females.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Genetically predicted hyperthyroidism and increased FT4 concentrations were positively associated with the risk of developing VTE. The effects of genetically predicted sex hormones on the risk of developing VTE differed between males and females. Greater genetically predicted estradiol concentrations were associated with an increased risk of developing VTE in females, while the SHBG rs858518 variant may become a potential prevention and treatment target for female VTE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-04039-y","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:25:16Z","timestamp":1721885116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The genetic effects of hormones modulated by the Pituitary-Thyroid\/Adrenal\/Gonadal axis on the risk of developing venous thromboembolism: a mendelian randomization study"],"prefix":"10.1186","volume":"24","author":[{"given":"Hao","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"issue":"11","key":"4039_CR1","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al. Thrombosis: a major contributor to global disease burden arteriosclerosis. Thromb Vascular Biology. 2014;34(11):2363\u201371.","journal-title":"Thromb Vascular Biology"},{"issue":"12","key":"4039_CR2","first-page":"1077","volume":"108","author":"A Squizzato","year":"2017","unstructured":"Squizzato A, Gerdes V, Brandjes D, Romualdi E, Zaane Bv, Stuijver D. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors. Thromb Haemost. 2017;108(12):1077\u201388.","journal-title":"Thromb Haemost"},{"issue":"6","key":"4039_CR3","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing G-J, et al. Antithrombotic therapy for VTE Disease. Chest. 2021;160(6):e545\u2013608.","journal-title":"Chest"},{"issue":"5","key":"4039_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1055\/s-0033-1343889","volume":"39","author":"B van Zaane","year":"2013","unstructured":"van Zaane B, Stuijver DJF, Squizzato A, Gerdes VEA. Arterial and venous thrombosis in Endocrine diseases. Semin Thromb Hemost. 2013;39(5):489\u201395.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"4039_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-0030-1270070","volume":"37","author":"A Squizzato","year":"2011","unstructured":"Squizzato A, van Zaane B, Gerdes VEA, B\u00fcller HR. The influence of Pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis. Semin Thromb Hemost. 2011;37(1):41\u20138.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"4039_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EJE-15-1249","volume":"174","author":"LPB Elbers","year":"2016","unstructured":"Elbers LPB, Moran C, Gerdes VEA, van Zaane B, Meijers JCM, Endert E, et al. The hypercoagulable state in hyperthyroidism is mediated via the thyroid hormone \u03b2 receptor pathway. Eur J Endocrinol. 2016;174(6):755\u201362.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"4039_CR7","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1210\/jc.2011-1661","volume":"96","author":"DJF Stuijver","year":"2011","unstructured":"Stuijver DJF, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, et al. Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a Multicenter Cohort Study. J Clin Endocrinol Metabolism. 2011;96(11):3525\u201332.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"4039_CR8","doi-asserted-by":"crossref","unstructured":"Wagner J, Langlois F, Lim DST, McCartney S, Fleseriu M. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing\u2019s Syndrome: A Systematic Meta-Analysis. Front Endocrinol. 2019;9.","DOI":"10.3389\/fendo.2018.00805"},{"key":"4039_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","volume":"192","author":"MY Abou-Ismail","year":"2020","unstructured":"Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40\u201351.","journal-title":"Thromb Res"},{"key":"4039_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trsl.2020.06.011","volume":"225","author":"N Machin","year":"2020","unstructured":"Machin N, Ragni MV. Hormones and thrombosis: risk across the reproductive years and beyond. Translational Res. 2020;225:9\u201319.","journal-title":"Translational Res"},{"issue":"6","key":"4039_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/aje\/kwm165","volume":"166","author":"Z Fewell","year":"2007","unstructured":"Fewell Z, Davey Smith G, Sterne JAC. The impact of residual and unmeasured confounding in epidemiologic studies: a Simulation Study. Am J Epidemiol. 2007;166(6):646\u201355.","journal-title":"Am J Epidemiol"},{"issue":"9302","key":"4039_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(02)07451-2","volume":"359","author":"DA Grimes","year":"2002","unstructured":"Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet. 2002;359(9302):248\u201352.","journal-title":"Lancet"},{"issue":"6","key":"4039_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1210\/clinem\/dgz225","volume":"105","author":"A Ku\u015b","year":"2020","unstructured":"Ku\u015b A, Chaker L, Teumer A, Peeters RP, Medici M. The genetic basis of thyroid function: Novel findings and New approaches. J Clin Endocrinol Metabolism. 2020;105(6):1707\u201321.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"4039_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12020-021-02867-y","volume":"75","author":"Y-S Yan","year":"2021","unstructured":"Yan Y-S, Qu Z, Lv P-p, Huang H-F. Pediatric and adult obesity concerns in female health: a mendelian randomization study. Endocrine. 2021;75(2):400\u20138.","journal-title":"Endocrine"},{"issue":"8","key":"4039_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"4","key":"4039_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, et al. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4(4):330\u201345.","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"4039_CR17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S. Efficient design for mendelian randomization studies: Subsample and 2-Sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177\u201384.","journal-title":"Am J Epidemiol"},{"key":"4039_CR18","doi-asserted-by":"crossref","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM et al. Guidelines for performing mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4.","DOI":"10.12688\/wellcomeopenres.15555.3"},{"issue":"2","key":"4039_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"4039_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"4039_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"4","key":"4039_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng.2213","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang J, Ferreira T, Morris AP, Medland SE, Madden PAF, Heath AC, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44(4):369\u201375.","journal-title":"Nat Genet"},{"key":"4039_CR23","doi-asserted-by":"crossref","unstructured":"Larsson SC, Allara E, Mason AM, Micha\u00eblsson K, Burgess S. Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases. Circulation: Genomic and Precision Medicine. 2019;12(3).","DOI":"10.1161\/CIRCGEN.118.002468"},{"issue":"9","key":"4039_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/thy.2021.0055","volume":"31","author":"C Ellervik","year":"2021","unstructured":"Ellervik C, Mora S, Ku\u015b A, \u00c5svold B, Marouli E, Deloukas P, et al. Effects of thyroid function on Hemostasis, Coagulation, and Fibrinolysis: a mendelian randomization study. Thyroid. 2021;31(9):1305\u201315.","journal-title":"Thyroid"},{"issue":"6","key":"4039_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/jth.12573","volume":"12","author":"J Debeij","year":"2014","unstructured":"Debeij J, van Zaane B, Dekkers OM, Doggen CJM, Smit JWA, van Zanten AP, et al. High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study. J Thromb Haemost. 2014;12(6):839\u201346.","journal-title":"J Thromb Haemost"},{"issue":"03","key":"4039_CR26","first-page":"249","volume":"44","author":"P Calabr\u00f2","year":"2017","unstructured":"Calabr\u00f2 P, Gragnano F, Golia E, von Grove E. Willebrand Factor and venous thromboembolism: pathogenic link and therapeutic implications. Semin Thromb Hemost. 2017;44(03):249\u201360.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"4039_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","volume":"132","author":"AM Randi","year":"2018","unstructured":"Randi AM, Smith KE, Castaman G. Von Willebrand factor regulation of blood vessel formation. Blood. 2018;132(2):132\u201340.","journal-title":"Blood"},{"issue":"6","key":"4039_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157(6):653\u201363.","journal-title":"Br J Haematol"},{"key":"4039_CR29","doi-asserted-by":"crossref","unstructured":"Alsaidan A, Alruwiali F. Association between hyperthyroidism and thromboembolism: a retrospective observational study. Ann Afr Med. 2023;22(2).","DOI":"10.4103\/aam.aam_105_22"},{"issue":"4","key":"4039_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jth.13970","volume":"16","author":"LPB Elbers","year":"2018","unstructured":"Elbers LPB, Fliers E, Cannegieter SC. The influence of thyroid function on the coagulation system and its clinical consequences. J Thromb Haemost. 2018;16(4):634\u201345.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4039_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1076029610364521","volume":"17","author":"M Franchini","year":"2010","unstructured":"Franchini M, Lippi G, Targher G. Hyperthyroidism and venous thrombosis: a casual or Causal Association? A systematic literature review. Clin Appl Thromb Hemost. 2010;17(4):387\u201392.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"4039_CR32","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Van Zaane","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MB, Fliers E, et al. Hypercoagulable State in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metabolism. 2009;94(8):2743\u201350.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"4039_CR33","doi-asserted-by":"crossref","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Dekkers OM, Cannegieter SC, J\u00f8rgensen JOL, Ehrenstein V et al. Use of glucocorticoids and risk of venous thromboembolism. JAMA Intern Med. 2013;173(9).","DOI":"10.1001\/jamainternmed.2013.122"},{"key":"4039_CR34","doi-asserted-by":"crossref","unstructured":"Santulli G, Allara E, Lee W-H, Burgess S, Larsson SC. Genetically predicted cortisol levels and risk of venous thromboembolism. PLoS ONE. 2022;17(8).","DOI":"10.1371\/journal.pone.0272807"},{"issue":"8","key":"4039_CR35","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jth.14474","volume":"17","author":"LJJ Scheres","year":"2019","unstructured":"Scheres LJJ, van Hylckama Vlieg A, Ballieux BEPB, Fauser BCJM, Rosendaal FR, Middeldorp S, et al. Endogenous sex hormones and risk of venous thromboembolism in young women. J Thromb Haemost. 2019;17(8):1297\u2013304.","journal-title":"J Thromb Haemost"},{"key":"4039_CR36","doi-asserted-by":"crossref","unstructured":"Luo S, Au Yeung SL, Zhao JV, Burgess S, Schooling CM. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank. BMJ. 2019.","DOI":"10.1136\/bmj.l476"},{"issue":"8","key":"4039_CR37","doi-asserted-by":"publisher","first-page":"e3078","DOI":"10.1210\/clinem\/dgab164","volume":"106","author":"M Nethander","year":"2021","unstructured":"Nethander M, Quester J, Vandenput L, Ohlsson C. Association of Genetically Predicted Serum Estradiol with risk of Thromboembolism in men: a mendelian randomization study. J Clin Endocrinol Metabolism. 2021;106(8):e3078\u201386.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"8","key":"4039_CR38","doi-asserted-by":"publisher","first-page":"e3275","DOI":"10.1210\/clinem\/dgab226","volume":"106","author":"BB Yeap","year":"2021","unstructured":"Yeap BB. Rates of Conversion of Testosterone to Estradiol May influence risk of venous thromboembolism in men. J Clin Endocrinol Metabolism. 2021;106(8):e3275\u20137.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"12","key":"4039_CR39","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1158\/1055-9965.EPI-08-0734","volume":"17","author":"DJ Thompson","year":"2008","unstructured":"Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, et al. Identification of Common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast Cancer risk in Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3490\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4039_CR40","doi-asserted-by":"crossref","unstructured":"Jasuja R, Spencer D, Jayaraj A, Peng L, Krishna M, Lawney B et al. Estradiol induces allosteric coupling and partitioning of sex-hormone-binding globulin monomers among conformational states. iScience. 2021;24(6).","DOI":"10.1016\/j.isci.2021.102414"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04039-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:29:08Z","timestamp":1721885348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04039-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04039-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the included GWASs obtained written informed consent from participants and were approved by the Ethics Committee. As we only extracted data from the GWASs database for analysis, no additional ethical review was required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}